Functional expression of a blood tolerant laccase in Pichia pastoris

Функциональная экспрессия устойчивой к крови лакказы в Pichia pastoris
Miguel Alcalde, Roland Ludwig, David González-Pérez, Diana M. Maté, Roman Kittl
2013-04-30

Pichia pastorisblood-tolerant laccasedirected evolutionfed-batch bioreactorhigh-redox potential laccase
BACKGROUND: Basidiomycete high-redox potential laccases (HRPLs) working in human physiological fluids (pH 7.4, 150 mM NaCl) arise great interest in the engineering of 3D-nanobiodevices for biomedical uses. In two previous reports, we described the directed evolution of a HRPL from basidiomycete PM1 strain CECT 2971: i) to be expressed in an active, soluble and stable form in Saccharomyces cerevisiae, and ii) to be active in human blood. In spite of the fact that S. cerevisiae is suited for the directed evolution of HRPLs, the secretion levels obtained in this host are not high enough for further research and exploitation. Thus, the search for an alternative host to over-express the evolved laccases is mandatory. RESULTS: A blood-active laccase (ChU-B mutant) fused to the native/evolved α-factor prepro-leader was cloned under the control of two different promoters (P(AOX1) and P(GAP)) and expressed in Pichia pastoris. The most active construct, which contained the P(AOX1) and the evolved prepro-leader, was fermented in a 42-L fed-batch bioreactor yielding production levels of 43 mg/L. The recombinant laccase was purified to homogeneity and thoroughly characterized. As happened in S. cerevisiae, the laccase produced by P. pastoris presented an extra N-terminal extension (ETEAEF) generated by an alternative processing of the α-factor pro-leader at the Golgi compartment. The laccase mutant secreted by P. pastoris showed the same improved properties acquired after several cycles of directed evolution in S. cerevisiae for blood-tolerance: a characteristic pH-activity profile shifted to the neutral-basic range and a greatly increased resistance against inhibition by halides. Slight biochemical differences between both expression systems were found in glycosylation, thermostability and turnover numbers. CONCLUSIONS: The tandem-yeast system based on S. cerevisiae to perform directed evolution and P. pastoris to over-express the evolved laccases constitutes a promising approach for the in vitro evolution and production of these enzymes towards different biocatalytic and bioelectrochemical applications.
1
A blood-active high-redox-potential laccase mutant was successfully expressed and secreted in Pichia pastoris using α-factor leader sequences.
2
Pichia pastoris processing generated the same extra N-terminal ETEAEF extension previously observed in Saccharomyces cerevisiae.
3
The Pichia-produced laccase retained directed-evolution improvements, including a neutral-basic pH-activity profile and strongly enhanced halide-inhibition resistance.
4
The best AOX1-promoter construct with the evolved prepro-leader produced 43 mg/L of recombinant laccase in a 42-L fed-batch bioreactor.
5
The two yeast systems showed modest differences in glycosylation, thermostability, and turnover numbers, supporting a tandem strategy using S. cerevisiae for evolution and P. pastoris for overexpression.

The blood-active high-redox-potential laccase ChU-B mutant expressed and secreted in Pichia pastoris

The recombinant laccase’s expression, secretion, biochemical properties, and blood tolerance, including pH-activity profile, halide-inhibition resistance, glycosylation, thermostability, and turnover numbers

Publication Details
Publication Date
2013-04-30
Journal
Publisher
ISSN
Cited by
43
Access Type
Author Information
Authors
Miguel Alcalde
Roland Ludwig
David González-Pérez
Diana M. Maté
Roman Kittl
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%